A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects
用户k7g3AjDeE8DM
9小时前
20
10
待确认
帖子自动结束时间: 2025-05-18 10:43:09
1. 请及时下载文件确认是否正确, 系统将在 2025-05-20 10:58:48 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s13318-025-00944-5
文献链接: https://link.springer.com/10.1007/s13318-025-00944-5
其他信息:
出版社: Springer Science and Business Media LLC
作者: Ying Wang; Yuanzhi Cheng; Yuhan Guo; Yang Fan; Renpeng Zhou; Qian Zhang; Ye Xu; Sheng Feng; Kai Shen; Wei Hu
全文下载地址: https://link.springer.com/content/pdf/10.1007/s13318-025-00944-5.pdf
